Our primary mission is to identify, isolate, and formulate natural bio-active molecules that can advantageously replace synthetic pharmaceutical ingredients and petroleum-derived bases. We help our partners formulate biosourced solutions that maintain or exceed the therapeutic efficacy of traditional synthetics.

Transitioning to botanical actives requires precise regulatory alignment. We provide expert guidance on structuring your formulations to comply with the European Medical Device Regulation (MDR) for physical/mechanical action devices, as well as EFSA guidelines for food supplements.

Utilizing our expansive academic network, we design bespoke formulations for Food Supplements and Substance-Based Medical Devices. From initial green-extraction technology mapping to pilot plant testing and semi-industrial scale production, we manage the entire lifecycle of your bio-innovation.

Led by our executive team with decades of experience in fine chemicals and international pharmaceuticals, we support the strategic implementation of these new bio-technologies into your existing portfolios, opening new avenues for premium market positioning and eco-ethical compliance.